WHO releases guidance on couples testing, counseling, including ART for discordant couples

The WHO on Wednesday released its new 54-page "Guidance on couples HIV testing and counselling, including antiretroviral therapy (ART) for treatment and prevention in serodiscordant couples: Recommendations for a public health approach," according to the Center for Global Health Policy's "Science Speaks" blog. "Intended for national policymakers and relevant health program managers in low- and middle-income countries with generalized HIV epidemics, the guidelines were set to be released at the International AIDS Conference in Rome last July, but delayed in order to consider results from two clinical trials looking at ART use as pre-exposure prophylaxis (PrEP) that showed a strong prevention benefit, as well as the relevance of couples counseling and testing among pairs who are men who have sex with men (MSM) and/or inject drugs," the blog notes. The guidance "also touches on recent evidence that pre-exposure prophylaxis (PrEP) with some antiretrovirals taken in discordant couples can help to prevent sexual acquisition of HIV, and notes that the WHO is reviewing this data and hopes to have a 'rapid advice' document on PrEP available sometime this year to help guide programs in discordant couples and in MSM communities," the blog states (Mazzotta, 4/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden becomes first country to meet global HIV targets